• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

安大略省初级保健团队药剂师主导的药物审查接受者中多重用药程度的描述性定量分析。

A Descriptive Quantitative Analysis on the Extent of Polypharmacy in Recipients of Ontario Primary Care Team Pharmacist-Led Medication Reviews.

作者信息

Benny Gerard Nichelle, Mathers Annalise, Laeer Christoph, Lui Eric, Kontio Tom, Patel Payal, Dolovich Lisa

机构信息

Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St, Toronto, ON M5S 3M2, Canada.

Family First Health Centre, 4270 Innes Rd, Orléans, ON K4A 5E6, Canada.

出版信息

Pharmacy (Basel). 2020 Jun 30;8(3):110. doi: 10.3390/pharmacy8030110.

DOI:10.3390/pharmacy8030110
PMID:32630000
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7558087/
Abstract

Pharmacist-led medication reviews have been shown to improve medication management, reducing the adverse effects of polypharmacy among older adults. This paper quantitatively examines the medications, medication discrepancies and drug therapy problems of recipients in primary care. A convenience sample of 16 primary care team pharmacists in Ontario, Canada contributed data for patients with whom they conducted a medication review over a prior four-week period. Data were uploaded using electronic data capture forms and descriptive analyses were completed. Two hundred and thirty-seven patients (on average, 67.9 years old) were included in the study, taking an average of 9.2 prescription medications ( ± 4.7). Majority of these patients (83.5%) were categorized as polypharmacy patients taking at least five or more prescribed drugs per day. Just over half of the patients were classified as having a low level of medication complexity (52.3%). Pharmacists identified 2.1 medication discrepancies ( ± 3.9) and 3.6 drug therapy problems per patient ( ± 2.8). Half these patients had more than one medication discrepancy and almost every patient had a drug therapy problem identified. Medication reviews conducted by pharmacists in primary care teams minimized medication discrepancies and addressed drug therapy problems to improve medication management and reduce adverse events that may result from polypharmacy.

摘要

由药剂师主导的药物评估已被证明能改善药物管理,减少老年人多重用药的不良反应。本文定量研究了初级保健中接受治疗者的药物、药物差异和药物治疗问题。加拿大安大略省16名初级保健团队药剂师的便利样本提供了他们在过去四周内对患者进行药物评估的数据。数据通过电子数据采集表上传并完成描述性分析。研究纳入了237名患者(平均年龄67.9岁),平均服用9.2种处方药(±4.7种)。这些患者中的大多数(83.5%)被归类为多重用药患者,即每天服用至少五种或更多处方药。略多于一半的患者被归类为药物复杂性较低(52.3%)。药剂师识别出每位患者有2.1个药物差异(±3.9个)和3.6个药物治疗问题(±2.8个)。这些患者中有一半存在不止一个药物差异,几乎每位患者都被识别出有药物治疗问题。初级保健团队中的药剂师进行的药物评估减少了药物差异,并解决了药物治疗问题,以改善药物管理并减少多重用药可能导致的不良事件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0c/7558087/cce09b1c8616/pharmacy-08-00110-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0c/7558087/2653ef87134c/pharmacy-08-00110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0c/7558087/d79120b0bd45/pharmacy-08-00110-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0c/7558087/cce09b1c8616/pharmacy-08-00110-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0c/7558087/2653ef87134c/pharmacy-08-00110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0c/7558087/d79120b0bd45/pharmacy-08-00110-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0c/7558087/cce09b1c8616/pharmacy-08-00110-g003.jpg

相似文献

1
A Descriptive Quantitative Analysis on the Extent of Polypharmacy in Recipients of Ontario Primary Care Team Pharmacist-Led Medication Reviews.安大略省初级保健团队药剂师主导的药物审查接受者中多重用药程度的描述性定量分析。
Pharmacy (Basel). 2020 Jun 30;8(3):110. doi: 10.3390/pharmacy8030110.
2
Appropriateness of Medications in Older Adults Living With Frailty: Impact of a Pharmacist-Led Structured Medication Review Process in Primary Care.衰弱老年人用药的适宜性:初级保健中由药剂师主导的结构化药物审查流程的影响
J Prim Care Community Health. 2019 Jan-Dec;10:2150132719890227. doi: 10.1177/2150132719890227.
3
Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled study.通过药物审查改善老年初级保健患者的药物治疗质量:一项随机对照研究。
Drugs Aging. 2013 Apr;30(4):235-46. doi: 10.1007/s40266-013-0057-0.
4
Pharmacist-Led Collaborative Medication Management for the Elderly with Chronic Kidney Disease and Polypharmacy.由药剂师主导的针对患有慢性肾脏病和多重用药的老年人的协作药物管理。
Int J Environ Res Public Health. 2021 Apr 20;18(8):4370. doi: 10.3390/ijerph18084370.
5
Drug therapy problems and medication discrepancies during care transitions in super-utilizers.频繁就医者在医疗转换期间的药物治疗问题和用药差异。
J Am Pharm Assoc (2003). 2016 Nov-Dec;56(6):633-642.e1. doi: 10.1016/j.japh.2016.07.004. Epub 2016 Oct 6.
6
Clinical pharmacist interventions in ambulatory psychogeriatric patients with excessive polypharmacy.临床药师干预门诊老年精神障碍患者过度用药。
Sci Rep. 2022 Jul 6;12(1):11387. doi: 10.1038/s41598-022-15657-x.
7
8
A shared medication scheme for community dwelling older patients with polypharmacy receiving home health care: role of the community pharmacist.针对接受家庭医疗护理且用药繁杂的社区老年患者的共享用药方案:社区药剂师的作用
Acta Clin Belg. 2019 Oct;74(5):326-333. doi: 10.1080/17843286.2018.1521903. Epub 2018 Sep 20.
9
Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer.评估药剂师主导的药物评估,以确定患有癌症的门诊老年患者中药物使用过多和潜在不适当用药的流行程度和相关因素。
J Clin Oncol. 2015 May 1;33(13):1453-9. doi: 10.1200/JCO.2014.58.7550. Epub 2015 Mar 23.
10
Pharmacist contributions to patient care and medical conditions present among recipients of Ontario primary care team pharmacist-led medication reviews: a qualitative analysis.药剂师对安大略省初级保健团队药剂师主导的药物审查接受者的患者护理和医疗状况的贡献:定性分析。
Int J Pharm Pract. 2021 Aug 11;29(4):385-388. doi: 10.1093/ijpp/riab023.

引用本文的文献

1
Can peer effects explain prescribing appropriateness? a social network analysis.同伴效应能否解释处方的适宜性?一项社会网络分析。
BMC Med Res Methodol. 2023 Oct 28;23(1):252. doi: 10.1186/s12874-023-02048-7.
2
Drug-Related Problems of Patients in Primary Health Care Institutions: A Systematic Review.基层医疗卫生机构患者的药物相关问题:一项系统综述
Front Pharmacol. 2021 Aug 17;12:698907. doi: 10.3389/fphar.2021.698907. eCollection 2021.
3
Primary care teams' experiences of delivering mental health care during the COVID-19 pandemic: a qualitative study.

本文引用的文献

1
Polypharmacy in older patients: identifying the need for support by a community pharmacist.老年患者的多种药物治疗:由社区药剂师确定是否需要支持。
BMC Geriatr. 2019 Oct 21;19(1):277. doi: 10.1186/s12877-019-1276-y.
2
Potentially inappropriate medications in older adults: a population-based cohort study.老年人潜在不适当用药:一项基于人群的队列研究。
Fam Pract. 2020 Mar 25;37(2):173-179. doi: 10.1093/fampra/cmz060.
3
Impact of pharmacists' interventions on the pharmacotherapy of patients with complex needs monitored in multidisciplinary primary care teams.
初级保健团队在 COVID-19 大流行期间提供精神卫生保健的经验:一项定性研究。
BMC Fam Pract. 2021 Jul 1;22(1):143. doi: 10.1186/s12875-021-01496-8.
4
The Evolving Role and Impact of Integrating Pharmacists into Primary Care Teams: Experience from Ontario, Canada.药剂师融入基层医疗团队的角色演变与影响:来自加拿大安大略省的经验
Pharmacy (Basel). 2020 Dec 7;8(4):234. doi: 10.3390/pharmacy8040234.
药剂师干预对多学科基层医疗团队监测的复杂需求患者药物治疗的影响。
Int J Pharm Pract. 2020 Feb;28(1):75-83. doi: 10.1111/ijpp.12577. Epub 2019 Aug 29.
4
Insights on multimorbidity and associated health service use and costs from three population-based studies of older adults in Ontario with diabetes, dementia and stroke.从安大略省三项基于人群的糖尿病、痴呆症和中风老年患者研究中了解共病及其相关的卫生服务利用和费用情况。
BMC Health Serv Res. 2019 May 16;19(1):313. doi: 10.1186/s12913-019-4149-3.
5
The REDCap consortium: Building an international community of software platform partners.REDCap 联盟:构建软件平台合作伙伴的国际社区。
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
6
Using Wisely: A Reminder on the Proper Use of the American Geriatrics Society Beers Criteria®.明智使用:关于正确使用美国老年医学会《Beers标准》®的提示。
J Am Geriatr Soc. 2019 Apr;67(4):644-646. doi: 10.1111/jgs.15766. Epub 2019 Jan 29.
7
American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults.美国老年医学学会 2019 年更新的老年人潜在不适当药物使用 AGS Beers 标准®。
J Am Geriatr Soc. 2019 Apr;67(4):674-694. doi: 10.1111/jgs.15767. Epub 2019 Jan 29.
8
International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action.减少不适当用药及多重用药国际组织(IGRIMUP):立场声明及十项行动建议
Drugs Aging. 2018 Jul;35(7):575-587. doi: 10.1007/s40266-018-0554-2.
9
Defining and measuring multimorbidity: a systematic review of systematic reviews.定义和测量多种疾病:系统综述的系统综述。
Eur J Public Health. 2019 Feb 1;29(1):182-189. doi: 10.1093/eurpub/cky098.
10
Activities performed by pharmacists integrated in family health teams: Results from a web-based survey.纳入家庭健康团队的药剂师所开展的活动:一项基于网络调查的结果
Can Pharm J (Ott). 2017 Oct 5;150(6):407-416. doi: 10.1177/1715163517733998. eCollection 2017 Nov-Dec.